HMGB1 and neoplasm: After Gly treatment in Msi2Transgenic CAC mice, HMGB1 blockade reduced immune infiltration within tumor tissues, as determined by findings such as the reductions in the migration and proportion of DCs, CD4+ T cells and CD8+ T cells and the production and secretion of inflammatory factors, cytokines and chemokines.